Multi-event August 2023 FDA Recall Sodium Flouride by Avkare Llc

This Multi-event Class II drug recall was voluntarily initiated by Avkare Llc on August 11, 2023 for the product Sodium Flouride. The FDA reported the reason for recall as cases of sodium fluoride 1.1% prescription dental toothpaste may contain cartons labeled as capsaicin cream 0.025% but contain correctly labeled tubes of sodium fluoride 1.1% prescription dental toothpaste. The product was distributed in Affected product was distributed to nineteen (19) consignees within the united states. and the recall is currently terminated.

Reported Recall Events

Recall Number: D-1146-2023

Reason for Recall
Cases of Sodium Fluoride 1.1% Prescription Dental Toothpaste may contain cartons labeled as Capsaicin Cream 0.025% but contain correctly labeled tubes of Sodium Fluoride 1.1% Prescription Dental Toothpaste
Initiated
08-11-2023
Reported
09-13-2023
Quantity
35,184 tubes

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Affected product was distributed to nineteen (19) consignees within the united states.
Sodium Fluoride 1.1%, SODIUM FLUORIDE Prescription Dental Toothpaste, 5000 ppm Fluoride Plus Mild Cleaning System Spearmint NET WT. 1.8 OZ. (51g), Rx only, NDC 42291-741-51, Manufactured for: AvKARE Pulaski, TN 38478

Batch or Lot Expiration Information

Lot# P23025 Exp. 02/24/2025

Affected Packages Involved in this Recall

Recall Number: D-1147-2023

Reason for Recall
Product mix-up: Cartons labeled Capsaicin Cream 0.025% may contain tubes of Sodium Fluoride 1.1% Prescription Dental Toothpaste
Initiated
08-11-2023
Reported
09-13-2023
Quantity
35,184 cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Affected product was distributed to nineteen (19) consignees within the united states.
Capsaicin Cream 0.025%, External Analgesic Cream, Penetrating Pain Relief, NET WT. 2.1 OZ. (60g) NDC 50268-195-60, Manufactured for: AvKARE, Pulaski, TN 38478

Batch or Lot Expiration Information

Lot# P22078; Exp. 11/30/2024

Affected Packages Involved in this Recall